RGLS logo

Regulus Therapeutics (RGLS) Return On Equity

Annual ROE

-141.77%
-56.69%-66.63%

December 31, 2023


Summary


Performance

RGLS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSprofitabilitymetrics:

Quarterly ROE

-53.07%
+2.40%+4.33%

September 30, 2024


Summary


Performance

RGLS Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

RGLS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-66.6%+4.3%
3 y3 years-107.5%+21.7%
5 y5 years+57.3%-104.4%

RGLS ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-180.2%at lowat high+51.4%
5 y5-year-180.2%+46.0%at high+92.8%
alltimeall time-873.9%+57.3%-104.4%+98.1%

Regulus Therapeutics ROE History

DateAnnualQuarterly
Sep 2024
-
-53.07%(-4.3%)
Jun 2024
-
-55.47%(-15.5%)
Mar 2024
-
-65.68%(-39.8%)
Dec 2023
-141.77%(+66.6%)
-109.19%(+15.9%)
Sep 2023
-
-94.22%(+10.4%)
Jun 2023
-
-85.35%(+5.4%)
Mar 2023
-
-81.01%(+17.7%)
Dec 2022
-85.08%(+68.1%)
-68.84%(+11.8%)
Sep 2022
-
-61.56%(-9.1%)
Jun 2022
-
-67.75%(+1.0%)
Mar 2022
-
-67.08%(-10.8%)
Dec 2021
-50.60%(-25.9%)
-75.20%(+1.7%)
Sep 2021
-
-73.95%(+21.3%)
Jun 2021
-
-60.96%(-33.0%)
Mar 2021
-
-91.00%(-10.6%)
Dec 2020
-68.33%(-74.0%)
-101.77%(-46.1%)
Sep 2020
-
-188.81%(-21.7%)
Jun 2020
-
-241.16%(-24.1%)
Mar 2020
-
-317.94%(-56.6%)
Dec 2019
-262.58%(-20.9%)
-732.43%(-160.2%)
Sep 2019
-
1216.00%(-143.3%)
Jun 2019
-
-2806.04%(+258.6%)
Mar 2019
-
-782.59%(+106.5%)
Dec 2018
-331.78%
-379.06%(+64.8%)
Sep 2018
-
-229.99%(+4.9%)
Jun 2018
-
-219.35%(+6.8%)
DateAnnualQuarterly
Mar 2018
-
-205.29%(+13.4%)
Dec 2017
-157.53%(+73.4%)
-181.03%(+10.3%)
Sep 2017
-
-164.10%(+11.6%)
Jun 2017
-
-147.08%(+32.5%)
Mar 2017
-
-111.04%(+21.7%)
Dec 2016
-90.85%(+108.7%)
-91.23%(+37.0%)
Sep 2016
-
-66.60%(+23.2%)
Jun 2016
-
-54.06%(+10.2%)
Mar 2016
-
-49.06%(+16.4%)
Dec 2015
-43.54%(-13.4%)
-42.14%(-27.1%)
Sep 2015
-
-57.81%(-2.8%)
Jun 2015
-
-59.45%(+7.3%)
Mar 2015
-
-55.40%(-7.4%)
Dec 2014
-50.28%(+109.5%)
-59.80%(+43.2%)
Sep 2014
-
-41.75%(+19.3%)
Jun 2014
-
-34.99%(+11.5%)
Mar 2014
-
-31.37%(+19.4%)
Dec 2013
-24.00%(-85.8%)
-26.28%(-53.1%)
Sep 2013
-
-56.08%(-51.0%)
Jun 2013
-
-114.39%(-71.6%)
Mar 2013
-
-402.65%(+3.5%)
Dec 2012
-169.02%(-1022.6%)
-388.87%(-1031.4%)
Sep 2012
-
41.75%(+3.0%)
Jun 2012
-
40.53%(+216.9%)
Mar 2012
-
12.79%(+73.5%)
Dec 2011
18.32%
7.37%

FAQ

  • What is Regulus Therapeutics annual return on equity?
  • What is the all time high annual ROE for Regulus Therapeutics?
  • What is Regulus Therapeutics annual ROE year-on-year change?
  • What is Regulus Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly ROE year-on-year change?

What is Regulus Therapeutics annual return on equity?

The current annual ROE of RGLS is -141.77%

What is the all time high annual ROE for Regulus Therapeutics?

Regulus Therapeutics all-time high annual return on equity is 18.32%

What is Regulus Therapeutics annual ROE year-on-year change?

Over the past year, RGLS annual return on equity has changed by -56.69% (-66.63%)

What is Regulus Therapeutics quarterly return on equity?

The current quarterly ROE of RGLS is -53.07%

What is the all time high quarterly ROE for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly return on equity is 1216.00%

What is Regulus Therapeutics quarterly ROE year-on-year change?

Over the past year, RGLS quarterly return on equity has changed by +2.40% (+4.33%)